ABPN C-L Psychiatry: The ICU Patient Who Holds His Arm Wherever It Is Placed

The ICU Patient Who Holds His Arm Wherever It Is Placed

Mr. K is a 23-year-old man with schizophrenia, off antipsychotics for six weeks, brought in by his parents after four days of not eating, not speaking, and holding odd postures. In the emergency department he was agitated and received haloperidol 5 mg IM three times over twelve hours. He is now in the ICU: temperature 39.1 C, heart rate 128, blood pressure 150/95, diaphoretic, rigid, mute, staring, and he keeps his arm raised wherever it is placed. CK 4,200, creatinine 2.1, WBC 15. No neck stiffness, no rash. He had one brief generalized seizure on arrival. The ICU team asks whether this is neuroleptic malignant syndrome or catatonia, whether to give dantrolene, and whether more haloperidol is acceptable. His parents want 'whatever usually works.'

1. How do you distinguish neuroleptic malignant syndrome from malignant catatonia in this patient, and does the distinction change what you do tonight?

Read the worked answer

They overlap, and the labels matter less than the first 24 hours. Both produce rigidity, fever, autonomic instability, altered consciousness, and elevated CK, and many authors regard them as points on one spectrum: antipsychotic exposure can convert a catatonic state into a malignant one.

Features favoring NMS: clear dopamine-antagonist exposure, lead-pipe rigidity, onset over one to three days, hyporeflexia, profuse diaphoresis, CK often above 1,000.

Features favoring catatonia: the motor signs themselves - posturing, waxy flexibility (his arm stays where placed), negativism, staring, mutism, stereotypy - appearing before the drug, plus a dramatic response to benzodiazepines. Score him with the Bush-Francis Catatonia Rating Scale now and after any challenge dose; that number is your most useful serial measure.

What changes tonight - and what does not:

Stop all antipsychotics either way. More haloperidol is not acceptable; it may have precipitated this.
Supportive care, cooling, fluids, monitoring of CK, potassium, and renal function are identical.
Benzodiazepines come first if catatonia is likely; dantrolene (1–2.5 mg/kg IV every 6 hours) and bromocriptine are for NMS and for persistent hyperthermia, not for catatonia per se.

Do not anchor on the psychiatric explanation. A 23-year-old with a first episode of psychosis, catatonia, and a seizure needs an LP and autoimmune/paraneoplastic encephalitis testing, including NMDA-receptor antibodies, plus HIV, urine toxicology, EEG, and head imaging. Anti-NMDA-receptor encephalitis presents exactly this way and is treatable. Also exclude serotonin syndrome, anticholinergic toxicity, sepsis, heat stroke, and thyrotoxicosis.

2. Give your immediate treatment plan and your threshold for escalating to ECT.

Read the worked answer

Tonight:

ICU-level supportive care: cooling, IV fluids targeting urine output, electrolyte and CK monitoring every 12 hours, DVT prophylaxis, aspiration precautions, bowel and bladder surveillance (retention and constipation perpetuate agitation), and no restraints if avoidable.
Stop every antipsychotic. No PRN haloperidol.
Lorazepam challenge: 2 mg IV (1–2 mg IM if access is poor) with BFCRS scoring before and 10–20 minutes after. A substantial drop is diagnostic as well as therapeutic.
If partial response, schedule lorazepam 2 mg IV every 6 hours, titrating to effect; some patients need 8–12 mg/day. Monitor sedation and respiratory status, and avoid indefinite high-dose infusions.
Continue the encephalitis workup in parallel; treat empirically if the picture is suggestive.

Escalation threshold: no meaningful improvement after 24–48 hours of adequate benzodiazepine dosing, or any progression - temperature above 39–40 C, autonomic instability, worsening renal function, rhabdomyolysis - moves to ECT. Catatonia is one of the most ECT-responsive conditions in psychiatry, and malignant catatonia is life-threatening; do not wait a week.

Practical ECT points: bilateral electrode placement, three times weekly initially, sometimes daily in malignant cases; a course may need 6–12 or more treatments; continue benzodiazepines as a bridge but keep the pre-procedure dose low enough not to raise the seizure threshold excessively. After recovery, avoid antipsychotics for at least two weeks and consider clozapine or maintenance ECT - restarting the same regimen that preceded this is a recipe for recurrence.

3. He cannot consent. How do you approach consent for ECT, and what else must be worked up before proceeding?

Read the worked answer

Capacity and consent:

Document that he lacks capacity for this decision: he is mute, posturing, and febrile.
Identify the legally recognized surrogate. Parents are not automatically health care agents; check the state statute and any advance directive or guardianship.
Meet the family with the ICU attending, explain the diagnosis, the natural history of untreated malignant catatonia (mortality is substantial), the efficacy of ECT, and the specific anesthetic and cardiac risks. Ask for their decision and elicit their goals for his recovery.
If the surrogate consents, proceed. If the surrogate refuses and his condition is deteriorating, use the jurisdiction's emergency provision with two-physician concurrence, hospital counsel, and the ethics committee - early, not at the moment he decompensates. This process varies by state and must be checked, not assumed.
Document the indication, the discussion, the surrogate's identity, and the legal basis.

Medical workup before the first treatment:

ECG and QTc, echocardiogram if any cardiac concern, electrolytes, magnesium, renal function, and glucose.
Anesthesia review for aspiration risk, positioning, and airway in a rigid, potentially hyperkalemic patient.
Neurology input and imaging; ECT can be delivered where he already is monitored, and ICU-based ECT is routine practice in malignant catatonia.
Anticipate hyperkalemia, rhabdomyolysis, and AKI from the seizure and rigidity; hydrate and monitor.

Frame the family discussion honestly: this is a treatment for a potentially fatal syndrome, not a punishment or a last resort, and the alternative - waiting - carries a worse prognosis.